Kuhnil Pharmaceutical received sales approval of 'Circadin' which is the world's only insomnia treatment
On June 27, Kuhnil Pharmaceutical announced that they received sales approval of 'Circadin' which is the world's only insomnia treatment with the ingredient of melatonin to the Ministry of Food and Drug Safety.
'Circadin' is the first sustained release melatonin agent which is similar to the rel...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
